DXCM - CIK 0001093557
DEXCOM INC trades as DXCM and has a market capitalization of $28.85 B, making it the #473 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $4.66B, up 15.6% from the prior year and net income of $836.30M. This page tracks DEXCOM INC through 2,566 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 9 fiscal years DEXCOM INC's revenue grew from $573.30M to $4.66B, a compound annual growth rate of 26.2%. Net profit margin expanded from -11.4% to 17.9% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Insider sale notice | 144 | 2026-05-21 |
| Insider trade | 4 | 2026-05-19 |
| Insider sale notice | 144 | 2026-05-15 |
| Major company event | 8-K | 2026-05-15 |
| Insider trade | 4 | 2026-05-14 |
| Insider sale notice | 144 | 2026-05-12 |
| Insider trade | 4 | 2026-05-11 |
| Insider trade | 4 | 2026-05-11 |
Dexcom Announces Governance Enhancements Ahead of 2026 Investor Day
SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM) today announced that it will host an Investor Day on Thursday, May 14,2026 from 1:15 PM until approximately 3:30 PM PDT (4:15 PM – 6:30 PM EDT). The event will include presentations from Dexcom management highlighting the company’s market opportunities, business strategy, innovation efforts, and long-term financial outlook.
Dexcom Reports First Quarter 2026 Financial Results
To listen to the conference call, please dial (888) 414-4585 (US/Canada) or (646) 960-0331 (International) and use the confirmation ID "9430114" approximately five minutes prior to the start time.
Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026
The largest companies sharing DEXCOM INC's SEC industry classification (surgical & medical instruments & apparatus).
DEXCOM INC (DXCM) has a market capitalization of $28.85 B as of 2026-06-10, ranking #473 among US-listed companies.
DEXCOM INC reported revenue of $4.66B for fiscal year 2025, an increase of 15.6% year over year.
Yes. DEXCOM INC reported net income of $836.30M in its latest fiscal year.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.